Morgan Stanley’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.34K | Sell |
11,340
-46,127
| -80% | -$25.8K | ﹤0.01% | 6968 |
|
|
2025
Q1 | $27.4K | Sell |
57,467
-213,558
| -79% | -$102K | ﹤0.01% | 6456 |
|
|
2024
Q4 | $274K | Sell |
271,025
-1,998,197
| -88% | -$2.02M | ﹤0.01% | 5670 |
|
|
2024
Q3 | $3.88M | Buy |
2,269,222
+2,040,609
| +893% | +$3.49M | ﹤0.01% | 4160 |
|
|
2024
Q2 | $583K | Buy |
228,613
+14,233
| +7% | +$36.3K | ﹤0.01% | 5223 |
|
|
2024
Q1 | $896K | Sell |
214,380
-345,476
| -62% | -$1.44M | ﹤0.01% | 5022 |
|
|
2023
Q4 | $1.86M | Buy |
559,856
+235,348
| +73% | +$781K | ﹤0.01% | 4962 |
|
|
2023
Q3 | $649K | Buy |
324,508
+137,339
| +73% | +$275K | ﹤0.01% | 5044 |
|
|
2023
Q2 | $591K | Buy |
187,169
+134,833
| +258% | +$426K | ﹤0.01% | 5126 |
|
|
2023
Q1 | $182K | Buy |
52,336
+28,249
| +117% | +$98K | ﹤0.01% | 5744 |
|
|
2022
Q4 | $124K | Buy |
24,087
+5,675
| +31% | +$29.1K | ﹤0.01% | 5887 |
|
|
2022
Q3 | $182K | Sell |
18,412
-392,373
| -96% | -$3.88M | ﹤0.01% | 5768 |
|
|
2022
Q2 | $3.45M | Buy |
410,785
+27,283
| +7% | +$229K | ﹤0.01% | 4092 |
|
|
2022
Q1 | $4.83M | Sell |
383,502
-62,914
| -14% | -$792K | ﹤0.01% | 3727 |
|
|
2021
Q4 | $7.08M | Buy |
446,416
+114,547
| +35% | +$1.82M | ﹤0.01% | 3346 |
|
|
2021
Q3 | $8.35M | Sell |
331,869
-4,354
| -1% | -$110K | ﹤0.01% | 3104 |
|
|
2021
Q2 | $9.87M | Buy |
+336,223
| New | +$9.87M | ﹤0.01% | 2998 |
|